Stifel Financial’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-27,134
| Closed | -$4.98M | – | 3478 |
|
|
2021
Q2 | $4.98M | Sell |
27,134
-8,224
| -23% | -$1.41M | 0.01% | 1028 |
|
|
2021
Q1 | $5.41M | Sell |
35,358
-90,933
| -72% | -$14.1M | 0.01% | 915 |
|
|
2020
Q4 | $19.7M | Buy |
126,291
+9,382
| +8% | +$1.21M | 0.04% | 397 |
|
|
2020
Q3 | $13.4M | Buy |
116,909
+5,420
| +5% | +$585K | 0.03% | 451 |
|
|
2020
Q2 | $12.5M | Sell |
111,489
-756
| -0.7% | -$80.3K | 0.03% | 439 |
|
|
2020
Q1 | $10.3M | Sell |
112,245
-3,439
| -3% | -$338K | 0.03% | 440 |
|
|
2019
Q4 | $12.6M | Buy |
115,684
+5,038
| +5% | +$539K | 0.03% | 513 |
|
|
2019
Q3 | $10.9M | Buy |
110,646
+11,571
| +12% | +$1.3M | 0.03% | 515 |
|
|
2019
Q2 | $12.9M | Buy |
99,075
+17,997
| +22% | +$2.32M | 0.03% | 475 |
|
|
2019
Q1 | $10.9M | Buy |
81,078
+13,263
| +20% | +$1.65M | 0.03% | 506 |
|
|
2018
Q4 | $6.68M | Buy |
67,815
+520
| +0.8% | +$61.5K | 0.02% | 635 |
|
|
2018
Q3 | $9.34M | Buy |
67,295
+5,763
| +9% | +$723K | 0.03% | 570 |
|
|
2018
Q2 | $7.57M | Buy |
61,532
+7,109
| +13% | +$831K | 0.02% | 632 |
|
|
2018
Q1 | $6.07M | Buy |
54,423
+2,915
| +6% | +$348K | 0.02% | 710 |
|
|
2017
Q4 | $6.18M | Buy |
51,508
+2,131
| +4% | +$260K | 0.02% | 690 |
|
|
2017
Q3 | $6.93M | Buy |
49,377
+4,518
| +10% | +$614K | 0.02% | 624 |
|
|
2017
Q2 | $5.45M | Sell |
44,859
-5,696
| -11% | -$663K | 0.02% | 683 |
|
|
2017
Q1 | $6.13M | Sell |
50,555
-38,073
| -43% | -$4.91M | 0.02% | 621 |
|
|
2016
Q4 | $10.8M | Sell |
88,628
-113,113
| -56% | -$13.8M | 0.05% | 389 |
|
|
2016
Q3 | $24.7M | Sell |
201,741
-24,355
| -11% | -$3.13M | 0.11% | 199 |
|
|
2016
Q2 | $26.4M | Sell |
226,096
-14,100
| -6% | -$2M | 0.12% | 182 |
|
|
2016
Q1 | $33.4M | Sell |
240,196
-61,965
| -21% | -$9.1M | 0.18% | 130 |
|
|
2015
Q4 | $57.7M | Sell |
302,161
-36,532
| -11% | -$6.38M | 0.3% | 83 |
|
|
2015
Q3 | $53M | Buy |
338,693
+94,419
| +39% | +$17.2M | 0.3% | 84 |
|
|
2015
Q2 | $44.2M | Buy |
244,274
+5,889
| +2% | +$1.02M | 0.23% | 116 |
|
|
2015
Q1 | $41.3M | Buy |
238,385
+24,366
| +11% | +$4.41M | 0.23% | 115 |
|
|
2014
Q4 | $39.6M | Buy |
214,019
+210,198
| +5,501% | +$38.9M | 0.22% | 113 |
|
|
2014
Q3 | $633K | Sell |
3,821
-505
| -12% | -$82.9K | 0.01% | 1384 |
|
|
2014
Q2 | $676K | Buy |
4,326
+181
| +4% | +$28.6K | 0.01% | 1313 |
|
|
2014
Q1 | $631K | Buy |
+4,145
| New | +$659K | 0.01% | 1307 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM